PCDH10 and gastric cancer: Numerous studies have indicated that aberrant methylation of Pcdh10 could be used as a non-invasive biomarker to facilitate diagnosis and prognostic guidance for gastric cancer patients (Deng et al. 2014; Hou et al. 2015; Schneider et al. 2015; Pimson et al. 2016).